← all drugs
Etomidate Injection
in shortage · Anesthesia · Snapshot: 2026-10-09
Day 1,465
of this shortage, counting from the FDA's first posting on 10/05/2022
- Manufacturers listed
- Hospira, Inc., a Pfizer Company, Caplin Steriles, Ltd., Eugia US LLC, Hikma Pharmaceuticals USA, Inc., Gland Pharma Limited, Mylan Institutional, a Viatris Company
- Reported reason(s)
- Demand increase for the drug; Other
- Machine-readable
- JSON for this drug
Presentations (18)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Etomidate, Injection, 2mg/1 mL (NDC 65219-445-10) | Caplin Steriles, Ltd. | Available | 06/16/2026 |
| Etomidate, Injection, 2mg/mL (NDC 65219-447-20) | Caplin Steriles, Ltd. | Available | 06/16/2026 |
| Etomidate, Injection, 2 mg/mL (NDC 72485-509-10) | Caplin Steriles, Ltd. | Available | 06/16/2026 |
| Etomidate, Injection, 20 mg/10 mL (NDC 55150-221-10) | Eugia US LLC | Unavailable | 10/02/2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Etomidate, Injection, 40 mg/20 mL (NDC 55150-222-20) | Eugia US LLC | Unavailable | 10/02/2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10) | Gland Pharma Limited | Available | 07/22/2026 |
| Amidate, Injection, 2 mg/mL (NDC 0409-6695-02) | Hospira, Inc., a Pfizer Company | Unavailable | 08/24/2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10) | Gland Pharma Limited | Available | 07/22/2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20) | Mylan Institutional, a Viatris Company | Available | 10/05/2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10) | Mylan Institutional, a Viatris Company | Available | 09/17/2026 |
| Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Etomidate, Injection, 2 mg/mL (NDC 72485-508-10) | Caplin Steriles, Ltd. | Available | 06/16/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.